DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Mycoplasma Testing Market Analysis By Product, By Technology (PCR, ELISA, Direct Assay, Microbial Culture Techniques), By Application (Cell Line, Virus, & End of Production Cells Testing), By End-use, And Segment Forecasts, 2014 - 2025" report to their offering.
The global mycoplasma testing market is expected to reach a value of USD 1.4 billion by 2025
With growing R&D investments in the field of life sciences, the demand for mycoplasma testing products are anticipated to rise in the near future. Huge opportunities in the life sciences segment are spurring the market growth. Hence, a large amount of investment is being made in the biotechnology and pharmaceutical industries with rising level of healthcare spending across the globe. This is expected to trigger high growth of mycoplasma testing market.
Investment in R&D activities by pharmaceutical and biotechnology companies is increasingly being supported by the government. Researches involving drug discovery and development, receive funding from the governmental bodies to a great extent. Moreover, governmental initiatives in the form of awareness campaigns for chronic diseases such as cancer are also encouraging research-based activities. Thus, the aforementioned factors are expected to drive the market growth.
Mycoplasma contamination of cell culture is a growing concern for most of the research scientists for decades. Mycoplasma infection arises majorly from laboratory workers as human mycoplasma contamination occurs at a faster rate. In order to combat further contamination, mycoplasma tests are being conducted, which is expected to increase the demand of the related products.
Some of the key players are Merck KGaA; Sigma-Aldrich Co.; Thermo Fisher Scientific; Lonza Group Ltd.; Charles River Laboratories International, Inc.; PromoCell GmbH; and Bionique Testing Laboratories, Inc.
Key Topics Covered:
1 Research Methodology
2 Executive Summary
3 Mycoplasma Testing Market Variables, Trends & Scope
4 Mycoplasma Testing: Product Estimates & Trend Analysis
5 Mycoplasma Testing: Technology Estimates & Trend Analysis
6 Mycoplasma Testing: Application Estimates & Trend Analysis
7 Mycoplasma Testing: End-Use Estimates & Trend Analysis
8 Mycoplasma Testing Market: Regional Estimates & Trend Analysis, by Product, Technology, Application, End-Use
9 Competitive Landscape
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Lonza Group Ltd.
- Promo Cell GmbH
- American Type Culture Collection
- Charles River Laboratories International, Inc.
- Bionique Testing Laboratories, Inc.
- Biological Industries Israel Beit Haemek Ltd.
- InvivoGen
For more information about this report visit http://www.researchandmarkets.com/research/mfs23g/mycoplasma
